Ferric Citrate 1 GM Oral Tablet [AURYXIA] + Placebo

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
69
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anemia, Iron Deficiency

Conditions

Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron

Trial Timeline

Mar 30, 2022 โ†’ Jan 24, 2024

About Ferric Citrate 1 GM Oral Tablet [AURYXIA] + Placebo

Ferric Citrate 1 GM Oral Tablet [AURYXIA] + Placebo is a phase 3 stage product being developed by Akebia Therapeutics for Anemia, Iron Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT05085275. Target conditions include Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05085275Phase 3Completed

Competing Products

20 competing products in Anemia, Iron Deficiency

See all competitors
ProductCompanyStageHype Score
AranespยฎAmgenApproved
84
KER-047Keros TherapeuticsPhase 2
44
LY2787106Eli LillyPhase 1
33
R744 + R744Chugai PharmaceuticalPhase 3
77
epoetin beta + placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietin placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietinChugai PharmaceuticalPhase 3
77
darbepoetin alfaAmgenPhase 3
76
PrasugrelDaiichi SankyoPhase 1
33
Prasugrel + PlaceboDaiichi SankyoPhase 2
52
roxadustatAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77
Roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77
AlefaceptAstellas PharmaPhase 1
33
RoxadustatAstellas PharmaPhase 2
52
roxadustatAstellas PharmaPhase 1
33
Roxadustat + PlaceboAstellas PharmaPhase 3
77
RoxadustatAstellas PharmaPre-clinical
23
Roxadustat + Epoetin AlfaAstellas PharmaPhase 3
77
roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77